Expression of a Chitinase Gene and Lysis of the Host Cell Wall during Chlorella Virus CVK2 Infection

AbstractA chitinase gene (vChti-1) encoded by the Chlorella virus CVK2 was cloned and characterized. The vChti-1 open reading frame consisted of 2508 bp corresponding to 836 amino acid residues. The predicted amino acid sequence contained two sets of a family 18 catalytic domain that is responsible for chitinase activity. Northern blot analysis revealed that the vChti-1 gene was expressed in virus-infected Chlorella cells late in infection, when a single transcript of about 2.5 kb appeared at 120 min postinfection. This result was confirmed by Western blotting with a specific anti-vChti-1 protein antibody; a protein of about 94 kDa was detected specifically beginning at 240 min postinfection and was present until cell lysis. The protein was not incorporated into viral particles but remained in the medium after cell lysis. The vChti-1 protein produced in virus-infected cells showed chitinase activity on zymogram assays

Combined Gastrectomy with Adjacent Organs in T4 Gastric Cancer : Therapeutic Results and Indication

The postoperative morbidity, mortality and survival of 244 T4 gastric cancer patients were examined to assess the therapeutic results and to clarify the indication for combined gastrectomy with adjacent (T4) organs. A total of 190 combined and 54 simple gastrectomies were performed during the 25-year period between 1969 and 1994. Fourteen (7.4%) and 7 (13.0%) patients died of the complications after combined and simple gastrectomies respectively. No statistical significant difference was found in the mortality rates between the gastrectomies. The histological examination of 190 resected specimens by the combined gastrectomy with T4 organs revealed that gastric resections with conclusive curability A, B and C were performed in 33 (17.4%), 84 (44.2%) and 73 (38.4%) cases respectively. Significant differences (P < 0.01) among 3 survival curves of the patients with curability A, B and C were found, and the 5-year survival rates were 65.5%, 35.4% and 9.2% respectively. The survival curve of 176 patients with combined gastrectomy was significantly (P < 0.01) higher than that of 47 patients with simple gastrectomy, and the 5-year survival rates were 31.3% and 4.3%. However, the survival curve and the 5-year survival rate of the patients with simple gastrectomy were not statistically different from those of the patients with curability C. These results suggest that combined gastrectomy with T4 organs in T4 gastric cancer may be indicated for the patients with surgical curability B, but not surgical curability C

ガン カンジャ ニ タイスル エイヨウ リョウホウ

Cancer cachexia has been defined as a multifactorial syndrome defined by an ongoing loss of skeletal mass that cannot be fully reserved by conventional nutritional support and lead to progressive functional impairment. The diagnostic criterion for cachexia is weight loss greater than 5％, or weight loss greater than 2％ in individuals already showing BMI＜20 or sarcopenia. Multimodal management plan including nutrition, exercise, ant-inflammatory strategies, and other adjuncts is required for all cancer patients with anti-cancer therapy （operation, chemotherapy, radiotherapy） to avoid weight loss and keep quality of life. Enteral nutrition by means of oral nutritional supplements and tube feeding offers ensuring nutrient intake in cases when normal food intake is in adequate. Routine parenteral nutrition in chemotherapy does not improve prognosis

ガン カンジャ ニ タイスル エイヨウ リョウホウ

Cancer cachexia has been defined as a multifactorial syndrome defined by an ongoing loss of skeletal mass that cannot be fully reserved by conventional nutritional support and lead to progressive functional impairment. The diagnostic criterion for cachexia is weight loss greater than 5％, or weight loss greater than 2％ in individuals already showing BMI＜20 or sarcopenia. Multimodal management plan including nutrition, exercise, ant-inflammatory strategies, and other adjuncts is required for all cancer patients with anti-cancer therapy （operation, chemotherapy, radiotherapy） to avoid weight loss and keep quality of life. Enteral nutrition by means of oral nutritional supplements and tube feeding offers ensuring nutrient intake in cases when normal food intake is in adequate. Routine parenteral nutrition in chemotherapy does not improve prognosis